- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 75 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Europe
- Training
- 75 Minutes
Global
- Training
- 90 Minutes
Global
- Report
- October 2023
- 146 Pages
Global
From €3265EUR$3,528USD£2,746GBP
€3841EUR$4,150USD£3,230GBP
- Report
- March 2024
- 77 Pages
Global
From €3500EUR$4,051USD£3,047GBP
- Report
- July 2024
- 132 Pages
Global
From €879EUR$950USD£739GBP
- Webinar
- May 2023
- 180 Minutes
Global
From €315EUR$340USD£265GBP
- Webinar
- May 2023
- 90 Minutes
Global
From €176EUR$190USD£148GBP
-
Journal - May 2025
- 60 Pages
Global
From €393EUR$425USD£331GBP
- Webinar
- May 2023
- 240 Minutes
Europe
From €458EUR$495USD£385GBP

Regulatory Affairs in the biotechnology industry is the process of obtaining and maintaining approval from regulatory authorities for the development, manufacture, and marketing of biotechnology products. This includes the submission of applications, such as Investigational New Drug (IND) applications, New Drug Applications (NDAs), and Biologics License Applications (BLAs). Regulatory Affairs professionals are responsible for ensuring that biotechnology products comply with applicable laws and regulations.
Regulatory Affairs professionals must have a thorough understanding of the regulatory environment and the ability to interpret and apply regulations to the development and marketing of biotechnology products. They must also be able to effectively communicate with regulatory authorities and other stakeholders.
Companies in the Regulatory Affairs market in the biotechnology industry include Parexel, Quintiles, Covance, PRA Health Sciences, and Charles River Laboratories. Show Less Read more